Sanofi SA (SASY.PA)

SASY.PA on Paris Stock Exchange

73.55EUR
6:04pm IST
Price Change (% chg)

€1.64 (+2.28%)
Prev Close
€71.91
Open
€73.32
Day's High
€74.28
Day's Low
€72.70
Volume
3,147,378
Avg. Vol
3,568,475
52-wk High
€89.95
52-wk Low
€68.29

SASY.PA

Chart for SASY.PA

About

Sanofi, formerly Sanofi-Aventis is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi focuses on the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer... (more)

Overall

Beta: 0.64
Market Cap (Mil.): €95,422.80
Shares Outstanding (Mil.): 1,326.97
Dividend: 2.80
Yield (%): 3.89

Financials

  SASY.PA Industry Sector
P/E (TTM): 23.30 33.49 33.67
EPS (TTM): 3.09 -- --
ROI: -- 18.10 17.39
ROE: -- 18.76 18.21
Search Stocks

BRIEF-Smith & Nephew CEO declines to comment on Sanofi CEO role

* Ceo olivier bohuon declines to comment on any interest in sanofi CEO role Further company coverage:

30 Oct 2014

UPDATE 3-Novo Nordisk reassures on 2015 outlook after Sanofi jolt

* Shares up almost 4 percent (Adds analysts, details on Tresiba, updates shares)

30 Oct 2014

Power of "France Inc" on display in Sanofi boardroom coup

PARIS, Oct 30 - Events at Sanofi this week cost a high-flying German-Canadian boss his job and global investors billions. They are also a reminder that corporate France carries the national interest in its DNA, and neglects its family duties at its peril.

30 Oct 2014

UPDATE 6-French drugmaker Sanofi sacks CEO, shares drop

* Chairman Weinberg cites poor relations between CEO, board

29 Oct 2014

BUSINESS-NEWS-SCHEDULE AT 1330 GMT /9.30 AM ET

Editor: Malcolm Davidson +44 20 7542 6958

29 Oct 2014

Behind the scenes of Sanofi's boardroom bust up

PARIS - A boardroom tussle brewing for months at Sanofi came to a head on Wednesday when France's top drugmaker fired its chief executive, wiping more billions off its share price.

29 Oct 2014

UPDATE 1-Behind the scenes of Sanofi's boardroom bust up

* Viehbacher wanted free hand to steer company (Recasts with eviction of CEO, Weinberg quotes, background)

29 Oct 2014

French drugmaker Sanofi sacks CEO Viehbacher

PARIS - Sanofi's board ousted its chief executive of six years at a special meeting on Wednesday, two days after it emerged he had fallen out with the French drugmaker's chairman, wiping more billions off its market value.

29 Oct 2014

European shares inch higher; Sanofi drops again

* FTSEurofirst 300 up 0.3 pct, Euro STOXX 50 up 0.1 pct * Fugro tumbles 21 pct after saying it won't pay dividend * STMicro drops after warning on revenue By Blaise Robinson PARIS, Oct 29 - European stocks inched higher early on Wednesday, tracking sharp gains on Wall Street ahead of a U.S. Federal Reserve policy announcement. At 0900 GMT, the FTSEurofirst 300 index of top European shares was up 0.3 percent at 1,321.07 points, led by miners including Rio Tinto and

29 Oct 2014

European shares rise ahead of Fed; Sanofi drops again

PARIS, Oct 29 - European shares rose early on Wednesday, tracking sharp gains on Wall Street ahead of the U.S. Federal Reserve's latest policy announcement.

29 Oct 2014

Earnings vs. Estimates

Search Stocks